Insurance Fraud Accountability Act
HB2079, titled the Insurance Fraud Accountability Act, would amend the Affordable Care Act to address fraudulent enrollments in qualified health plans sold through ACA Exchanges. The bill focuses primarily on agents, brokers, and related marketing entities involved in the enrollment process, creating new penalties for negligent, knowing, and willful submission of false or fraudulent information. It also directs the Secretary of Health and Human Services to establish verification and oversight procedures for broker-assisted enrollments, especially in federally operated Exchanges.
The bill would require stronger consumer protections during enrollment changes, including proof of consumer consent, delayed commission payments until inconsistencies are resolved, timely notice to consumers about enrollment or agent changes, and easier access to account information and cancellation options for unauthorized activity. It also expands federal authority over field marketing organizations and third-party marketing organizations, defines those entities and the “chain of enrollment,” and requires standards such as best-interest conduct, marketing review, registration, and limits on referral compensation. In addition, it mandates audits, sharing of audit results with state insurance departments, and regular lists of suspended or terminated agents and brokers for Exchanges, insurers, and states.
The bill would amend sections 1411, 1311, and 1312 of the Patient Protection and Affordable Care Act, adding new federal enforcement tools and consumer-protection requirements for Exchange enrollment activity. It would expose agents and brokers to civil penalties of $10,000 to $50,000 per affected individual for negligent false information, up to $200,000 per affected individual for knowing false or fraudulent information, and criminal penalties of up to 10 years imprisonment for knowing and willful fraud. It would also require HHS to establish verification, audit, reporting, and oversight systems for broker-assisted enrollments and related marketing organizations, with implementation targeted for plan years beginning no later than January 1, 2029.
The bill appears to have a generally protective, anti-fraud orientation, with its stated purpose centered on accountability and consumer safeguards in ACA enrollment. Because there are no recorded votes or committee transcripts in the provided material, there is no documented floor or committee debate to indicate broader partisan or stakeholder sentiment. Based on the text alone, the measure is framed as a response to enrollment fraud and unauthorized plan changes, suggesting support from consumer-protection and insurance-integrity perspectives.
The main points of potential contention are the bill’s expanded federal oversight of agents, brokers, and marketing organizations, and the new compliance burdens imposed on enrollment intermediaries. Industry participants could object to mandatory audits, marketing-material review, registration requirements, reporting of termination information, and restrictions on compensation for referrals. Another possible point of debate is the scope of the penalties and the requirement that brokers prove consumer consent before commissions are paid, which may be viewed as necessary fraud prevention by supporters but as administratively burdensome or duplicative by critics. The bill also gives the Secretary substantial discretion to define standards and procedures, which could raise concerns about regulatory reach.